Sep 2026· JPMA. The Journal of the Pakistan Medical Association· Vol 76(Suppl 1) 9, pp.
S37
· 0 citations
Medicine
TL;DR
A young adult who developed osseous and hepatic metastases from an IDH-wildtype grade 4 astrocytic glioma is described, which shows a rhabdoid high-grade tumour whose profile matched the primary (GFAP positive, IDH1 negative, p53-mutant).
Abstract
Objectives
High-grade astrocytic gliomas rarely spread outside the central nervous system, held back by the blood- brain barrier, the absence of CNS lymphatics, and short survival. We describe a young adult who developed osseous and hepatic metastases from an IDH-wildtype grade 4 astrocytic glioma.
Method
A 26-year-old man had maximal safe resection on 17 April 2025 (diffuse astrocytoma, NOS, CNS WHO grade 4, IDH-wildtype), at the Aga Khan University Hospital, Karachi, Pakistan. This was followed by chemoradiotherapy that finished on 16 July 2025, maintenance temozolomide, and later bevacizumab with irinotecan. On 28 May 2026 he reported new pain; whole-spine MRI found osseous metastases through the spine and pelvis and hepatic deposits, without leptomeningeal disease, and FDG PET/CT on 2 June 2026 showed these lesions were hypermetabolic. A liver biopsy was performed. Consent of the patient was obtained for publishing his case.
Results
The liver biopsy results showed a rhabdoid high-grade tumour whose profile matched the primary (GFAP positive, IDH1 negative, p53-mutant).
Conclusions
Immunophenotyping separates true metastasis from a second cancer.
Brain metastases from ovarian cancer are uncommon, with an estimated incidence of 1%-3%, and are usually associated with advanced-stage disease and prolonged survival. We report the case of a 55-year-old woman diagnosed with metastatic high-grade serous ovarian carcinoma presenting with diffuse peritoneal carcinomatosi...
N. Berrada, Soufiane Bigi, R. Mokfi et al.· Radiology Case Reports· 0 citations
A 37-year-old woman who presented with long-standing right temporal-parietal headache and acute worsening with vomiting is reported, highlighting a rare pattern of primary extracranial extension in GBM and suggesting direct contiguous transdural invasion as a plausible route of spread in the absence of prior interventi...
Jian-Hang Lin, Jia-Yi Lin, Jia-Na Zhang et al.· Frontiers in Medicine· 0 citations
Background: Anaplastic oligodendroglioma (WHO grade III) is a relatively uncommon glioma defined by IDH mutation and 1p/19q codeletion and is often associated with comparatively favorable outcomes following maximal surgical resection and adjuvant chemoradiotherapy. Reports describing fatal delayed neurological and syst...
Mohib Ullah Khan, Izaz Riaz, Usman Benyamin et al.· Journal of Saidu Medical Col...· 0 citations
Introduction: Pulmonary pleomorphic carcinoma is a rare, highly aggressive subtype of lung cancer with frequent early multiple-organ metastases including to the brain. However, brain metastases that precede detection of a primary lung lesion are exceedingly rare. We report a case of pulmonary pleomorphic carcinoma with...
Kohei Miyagi, M. Kimura, Ryusei Nobori et al.· Case Reports in Neurology· 0 citations
Background: Primary spinal cord gliomas are rare, with adult-onset diffuse midline glioma (DMG), H3K27-altered, representing an even smaller and highly aggressive subset. Recently classified as a World Health Organization (WHO) Grade 4 entity, these tumors typically arise in midline structures and carry a poor prognosi...
Halit Alioğlu, Mert Yavuz, O. Alomarı et al.· Surgical neurology internati...· 0 citations
ABSTRACT INTRODUCTION Meningioma is one of the most common central nervous system tumors; however, metastatic lesions are extremely rare. Particularly, hepatic metastasis from meningioma is uncommon, and its diagnosis and optimal management remain undefined. CASE PRESENTATION A 70-year-old man with a history of left pa...
Yuki Hirase, Haruhi Fukuhisa, Akihiko Sakamoto et al.· Surgery Case Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.